CPT code 85245: vWF activity, ristocetin cofactor assay2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Measures von Willebrand factor activity through a ristocetin-based assay, supporting evaluation of bleeding symptoms and suspected von Willebrand disease.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide5.9K Medicare services in 2024

Medicare pays $22.94 for 85245 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$22.94

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 85245 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 85245 covers

This coagulation laboratory assay measures von Willebrand factor (vWF) activity using ristocetin-dependent platelet agglutination. It evaluates vWF function rather than the amount of vWF antigen or factor VIII activity. Hematology and coagulation laboratories perform the test for clinicians evaluating mucocutaneous bleeding, an abnormal bleeding history, or suspected von Willebrand disease, and to characterize functional vWF defects.

Report 85245 when the ordered and performed test is the ristocetin cofactor activity assay. It may be part of a broader von Willebrand disease evaluation with vWF antigen and factor VIII activity testing; those are distinct laboratory services. Medicare pays this code only under the CLFS, at one national amount in every state and locality, without geographic or office-versus-facility adjustment. The 2026 national CLFS amount is $22.94, unchanged since 2020. The test is excluded from the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 85245

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 85245. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 85245 with status X (excluded by statute), so the test itself is paid only from the CLFS.

85245 on the lab fee schedule since 2020

85245 · CLFS 2026 Q4 (current)

$22.94

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

85245 compared with similar tests

85246vWF antigenAntigen concentration$22.94
Choose 85245 for ristocetin cofactor activity and 85246 for vWF antigen quantity; the assays measure different properties.
85247VWF multimer testMultimer distribution$22.94
Code 85247 assesses vWF multimer distribution, not the ristocetin-based functional activity measured by 85245.
85240Factor VIIIOne-stage activity$17.90
Code 85240 measures factor VIII activity. It is distinct from the vWF activity assay reported with 85245.

85245 billing questions

How does 85245 differ from vWF antigen testing?

85245 measures vWF function with a ristocetin-based assay. Code 85246 measures vWF antigen, reflecting the amount of the protein rather than its activity.

Can 85245 be reported with factor VIII activity?

Yes. Code 85240 measures factor VIII activity, a separate result that may be obtained alongside vWF activity during evaluation for von Willebrand disease.

What documentation supports reporting 85245?

The order and laboratory record should identify the ristocetin cofactor activity assay and its result, rather than only a vWF antigen or multimer study.

How does Medicare pay for 85245?

Medicare pays it through the CLFS at one national amount that applies across localities and in office and facility settings. It is excluded from the physician fee schedule.

Is 85245 the same test as a vWF multimer analysis?

No. Code 85245 evaluates vWF activity, while 85247 examines the distribution of vWF multimers.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 85245PUF_CLFS_CY2026_Q4V1.csv, line 1,554 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 85245?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 85245 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist